August 2018 as follows: 1. To approve payment of interim dividend for the operating results of January to June 2018 from net profit and retained earnings under the Company's financial statement, to the
from marketing of the new clients at the end of , KT Medical Services Co., Ltd. provides health care facilities for patients with end-stage chronic kidney disease who receive replacement therapy with
, the Company had the net profit attributable to equity holders of the Company before gain on fair value adjustment of investment due to reclassification in the amount of Baht 1,089 Million representing
lower revenue, higher administrative expenses, and a recognition of share of net losses from investments by the equity method. The Company reported net loss of THB 23 million compared to net profit of THB
end-stage renal disease treated with hemodialysis machine ("Hemodialysis Center"). Currently, there are 5 Hemodialysis Center (with 6 3 dialysis machines), 1 hemodialysis center in Bangkok, 3
its plan for the project at soi Sukhumvit 19 from developing a condominium to develop a 4 stars hotel. The current progress is on design stage and choosing hotel brand operator. The Company targets to
12% (71%) 100 79 (21%) Gross profit 251 378 384 2% 53% 774 1,248 61% SG&A expenses (237) (422) (405) 4% (71%) (733) (1,241) (69%) Other income 76 87 56 (36%) (27%) 376 213 (43%) EBITDA 141 115 91 (21
Medical Services Co., Ltd. provides health care facilities for Management's Discussion and Analysis and operating results for the Quarter 1’ 2018 Page 2 / 6 patients with end-stage renal disease treated
Expenses 1,148.8 2,103.6 1,123.0 (954.8) (45.4%) 25.8 2.3% Profit for the period 59.7 132.8 102.8 (73.1) (55.0)% (43.1) (41.9)% Overall, the global economy is likely to slow down significantly due to the
Expenses 1,148.8 2,103.6 1,123.0 (954.8) (45.4%) 25.8 2.3% Profit for the period 59.7 132.8 102.8 (73.1) (55.0)% (43.1) (41.9)% Overall, the global economy is likely to slow down significantly due to the